Parallel Biosystems, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Parallel Biosystems, Inc. - overview
Established
2021
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2021 by its CEO Robert M. DiFazio, and CSO Juliana L. Hilliard, Parallel Biosystems, Inc. operates as a biotech company that develops replicates of the human immune system in a dish for drug discovery and development.
In June 2025, Parallel Biosystems, Inc. raised USD 21 million in series A funding led by new investor AIX Ventures, with participation from another new investor Amplo. Returning investors Metaplanet Holdings, Susa Ventures, Atypical Ventures, Undeterred Capital and individual investors also participated in the round. Parallel Biosystems, Inc.
develops a platform that combines human immune organoids with artificial intelligence and robotics to analyze the hundreds of cells and thousands of molecules that comprise the immune system and generate unprecedented insights into human health and disease. The immune organoid, which is a mini human lymph node, each organoid is about the size of a pencil eraser and has all the same molecules, cells, and structures found in human lymph nodes. The company plans to use the series A funding to support the further development of its AI and automation capabilities, expand its team of scientists and engineers, and sign new pharmaceutical partnerships.
Current Investors
Y Combinator, Breakout Ventures, Refactor Capital
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Bioinformatics, Healthcare IT, Pharmaceutical Research & Development, Scientific Software
Website
www.parallel.bio
Verticals
Artificial Intelligence, Artificial Intelligence, Artificial Intelligence, Big Data, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Parallel Biosystems, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.